Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice

BCG is currently the only licensed vaccine against tuberculosis (TB) and confers protection against meningitis and miliary tuberculosis in infants, although pulmonary disease protection in adults is inconsistent. Recently, promising HIV-1 immunogens were developed, such as the T-cell immunogens “tHI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilpeläinen, Athina, Saubi, Narcís, Guitart, Núria, Moyo, Nathifa, Wee, Edmund G., Ravi, Krupa, Hanke, Tomáš, Joseph, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530512/
https://www.ncbi.nlm.nih.gov/pubmed/31156614
http://dx.doi.org/10.3389/fimmu.2019.00923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530512/
https://www.ncbi.nlm.nih.gov/pubmed/31156614
http://dx.doi.org/10.3389/fimmu.2019.00923

Ejemplares similares